Skip to content
First News
Menu
  • BUSINESS
  • ARTICLES
  • SENIOR LEADERSHIP
  • FEATURES
  • BusinessWireIndia
Menu

Pidilite appoints Mr. Sudhanshu Vats as Managing Director & Mr. Kavinder Singh as Joint Managing Director

Posted on April 2, 2025April 2, 2025 by S Joseph


 

The Board of Directors of the Company has approved the appointment of Mr. Sudhanshu Vats as Managing Director and appointment of Mr. Kavinder Singh as Joint Managing Director, in its Board Meeting held on 1st April 2025. This change will be effective from 10th April 2025, after the completion of the term of the current Managing Director, Mr. Bharat Puri who has been the Managing Director of the Company for a decade since 10th April 2015.

The Board expressed its deep appreciation and gratitude for the valuable contributions made by Mr. Bharat Puri during his tenure as Managing Director of the Company.

 

The Board of Directors also appointed Mr. Bharat Puri as Non-Executive and Non-Independent Director of the Board of the Company for a term of 3 years commencing from 10th April 2025 to 9th April 2028.

 

Commenting on the announcement, Mr. M. B. Parekh, Executive Chairman of the Company, said “We thank Bharat for his invaluable contribution as Managing Director for the last 10 years. Pidilite has made substantial progress and created significant shareholder value during his term. The appointments of Sudhanshu and Kavinder as MD and Joint MD will reflect the next phase of the Pidilite leadership journey. I look forward to working with the two of them in building the Pidilite of the future”.

LATEST NEWS

  • Crayons Marks 40 Years of Independent Growth, Reinforces Focus on AI and Integrated Marketing
  • Scoot’s July Thematic Sale Offers Discounted Fares Starting at INR 10,500
  • Sambhuti Learning & Prosical Language Technologies Sign MoU at SINE, IIT Bombay to Advance AI-Powered Reading Assessment​
  • ZF Group India Wins Three Independent Orders for Test Systems- Enabling Battery, Tyre and E-Axle Testing
  • Immuneel and Arogya Finance Launch India’s First Zero Cost EMI Program of up to ₹25 Lakhs for Qartemi® (Varnimcabtagene autoleucel) CAR-T Cell Therapy

Past News

  • July 2026 (16)
  • June 2026 (60)
  • May 2026 (57)
  • April 2026 (87)
  • March 2026 (83)
  • February 2026 (68)
  • January 2026 (75)
  • December 2025 (72)
  • November 2025 (49)
  • October 2025 (102)
  • September 2025 (97)
  • August 2025 (88)
  • July 2025 (91)
  • June 2025 (84)
  • May 2025 (90)
  • April 2025 (80)
  • March 2025 (80)
  • February 2025 (61)
  • January 2025 (56)
  • December 2024 (46)
  • November 2024 (48)
  • October 2024 (66)
  • September 2024 (53)
  • August 2024 (42)
  • July 2024 (35)
  • June 2024 (33)
  • May 2024 (35)
  • April 2024 (40)
©2026 First News | Design: Newspaperly WordPress Theme